Header Logo

A Phase 1b/2 Study of Atezolizumab with or Without Bacille Calmette-Gu?rin in Patients with High-risk Non-muscle-invasive Bladder Cancer.

A Phase 1b/2 Study of Atezolizumab with or Without Bacille Calmette-Gu?rin in Patients with High-risk Non-muscle-invasive Bladder Cancer. Eur Urol Oncol. 2023 Feb 15.

View in: PubMed